Last $7.09 USD
Change Today +0.28 / 4.11%
Volume 3.4M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for ariad pharmaceuticals inc (ARIA)

Year over year, Ariad Pharmaceuticals Inc. has seen their bottom line shrink from a loss of $220.9M USD to an even larger loss of $274.2M USD despite an increase in revenues from $558.0K USD to $45.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues179.025.30.645.6
TOTAL REVENUES179.025.30.645.6
Cost of Goods Sold24.1----9.6
GROSS PROFIT154.925.30.635.9
Selling General & Admin Expenses, Total16.124.460.9144.0
R&D Expenses32.277.7139.9160.7
OTHER OPERATING EXPENSES, TOTAL48.3102.1200.8304.7
OPERATING INCOME106.6-76.8-200.3-268.8
Interest Expense-0.2-0.2-0.2-0.2
Interest and Investment Income0.10.20.20.1
NET INTEREST EXPENSE-0.1-0.10.00.0
Currency Exchange Gains (Loss)----0.1-0.1
Other Non-Operating Income (Expenses)-19.5-46.7-15.9--
EBT, EXCLUDING UNUSUAL ITEMS86.9-123.6-216.1-268.9
Merger & Restructuring Charges-------4.8
Other Unusual Items, Total-1.7---4.8--
Other Unusual Items0.7------
EBT, INCLUDING UNUSUAL ITEMS85.2-123.6-220.9-273.7
Income Tax Expense------0.4
Earnings from Continuing Operations85.2-123.6-220.9-274.2
NET INCOME85.2-123.6-220.9-274.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS85.2-123.6-220.9-274.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS85.2-123.6-220.9-274.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $7.09 USD +0.28

ARIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $3.42 USD -0.15
Array BioPharma Inc $4.75 USD +0.11
Insys Therapeutics Inc $42.24 USD +0.72
Pfizer Ltd/India 2,038 INR 0.00
Progenics Pharmaceuticals Inc $7.24 USD +0.25
View Industry Companies
 

Industry Analysis

ARIA

Industry Average

Valuation ARIA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 28.3x
Price/Book 16.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 19.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.